Friday, July 30, 2021

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business As a part of the transaction, Lupin will gain access to over 60 registered products having sales of over AUD 30 million

from Moneycontrol Business News https://ift.tt/3BWpqWx

No comments:

Post a Comment

Vijay Kedia-backed cybersecurity stock announces 1:1 bonus issue. Check details

Shares of Vijay Kedia-backed TAC Infosec rose on news of a one-for-one bonus issue, backed by strong financial performance, including a 157%...